TRIALS is a dynamic team of researchers aiming to identify new treatments for a range of disorders. Innovation and cross-collaboration are the cornerstones of our research program.
Professor Olivia Dean
Director, Deakin Clinical Trials Hub
About our work
IMPACT TRIALS works with collaborators both nationally and internationally. There have been a number of completed trials with agents including; N-acetyl cysteine, minocycline, mitochondrial enhancers, asprin, and rosuvastatin. Data from these trials provides rich sources to explore not only primary efficacy but also underlying factors related to treatment response.
TRIALS ultimately aims both to provide interventions that can be rolled out into clinical practice and to identify factors that will enhance personalised medicine in psychiatry
Studies
See below our upcoming, current and past studies at IMPACT TRIALS
RECONNECT AFTER STROKE
TRI-ME Trial: A new treatment trial for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
The Silexan in the Treatment Of Posttraumatic stress disorder (STOP) Trial
WellCom Study: Recruitment of healthy participants to investigate blood markers relevant to psychiatric disorders.
Strive to Thrive after stroke
Tina Trial
Caring about return to work after a stroke
Returning to work after stroke in rural communities
BipolarASSIST: A new program for family and friends of people with bipolar disorder
BipolarWISE: A new program about living well with bipolar disorder
RESET (Resuming Employment after Stroke- Enhancement through Telecoordination) Advisory Network
CADET-UD Trial: Candesartan for major depressive disorder
CADET-BD Trial: Candesartan for bipolar disorder
DepressionASSIST: Psychoeducation website for close family friends of adults with major depressive disorder
Coping with COVID-19
RESET: Resuming Employment after Stroke: Enhancement through Telecoordination